Olsen Dorte Aa, Petersen Steen V, Oury Tim D, Valnickova Zuzana, Thøgersen Ida B, Kristensen Torsten, Bowler Russel P, Crapo James D, Enghild Jan J
Department of Molecular Biology, University of Aarhus, DK-8000 Arhus, Denmark.
J Biol Chem. 2004 May 21;279(21):22152-7. doi: 10.1074/jbc.M401180200. Epub 2004 Mar 24.
Extracellular superoxide dismutase (EC-SOD) is a tetramer composed of either intact (Trp(1)-Ala(222)) or proteolytically cleaved (Trp(1)-Glu(209)) subunits. The latter form is processed intracellularly before secretion and lacks the C-terminal extracellular matrix (ECM)-binding region ((210)RKKRRRESECKAA(222)-COOH). We have previously suggested that the C-terminal processing of EC-SOD is either a one-step mechanism accomplished by a single intracellular endoproteolytic event cleaving the Glu(209)-Arg(210) peptide bond or a two-step mechanism involving two proteinases (Enghild, J. J., Thogersen, I. B., Oury, T. D., Valnickova, Z., Hojrup, P., and Crapo, J. D. (1999) J. Biol. Chem. 274, 14818-14822). In the latter case, an initial endoproteinase cleavage occurs somewhere in the region between Glu(209) and Glu(216). A carboxypeptidase specific for basic amino acid residues subsequently trims the remaining basic amino acid residues to Glu(209). A naturally occurring mutation of EC-SOD substituting Arg(213) for Gly enabled us to test these hypotheses. The mutation does not prevent proteolysis of the ECM-binding region but prevents a carboxypeptidase B-like enzyme from trimming residues beyond Gly(213). The R213G mutation is located in the ECM-binding region, and individuals carrying this mutation have an increased concentration of EC-SOD in the circulatory system. In this study, we purified the R213G EC-SOD variant from heterozygous or homozygous individuals and determined the C-terminal residue of the processed subunit to be Gly(213). This finding supports the two-step processing mechanism and indicates that the R213G mutation does not disturb the initial endoproteinase cleavage event but perturbs the subsequent trimming of the C terminus.
细胞外超氧化物歧化酶(EC-SOD)是一种四聚体,由完整的(色氨酸(1)-丙氨酸(222))或经蛋白水解切割的(色氨酸(1)-谷氨酸(209))亚基组成。后一种形式在分泌前在细胞内进行加工,并且缺乏C末端细胞外基质(ECM)结合区域((210)RKKRRRESECKAA(222)-COOH)。我们之前曾提出,EC-SOD的C末端加工要么是由单个细胞内内切蛋白酶切割谷氨酸(209)-精氨酸(210)肽键完成的一步机制,要么是涉及两种蛋白酶的两步机制(恩希尔德,J. J.,托格森,I. B.,乌里,T. D.,瓦尔尼科娃,Z.,霍伊鲁普,P.,和克拉波,J. D.(1999年)《生物化学杂志》274,14818 - 14822)。在后一种情况下,初始内切蛋白酶切割发生在谷氨酸(第209位)和谷氨酸(第216位)之间的某个区域。随后,一种对碱性氨基酸残基具有特异性的羧肽酶将剩余的碱性氨基酸残基修剪为谷氨酸(第209位)。EC-SOD的一种天然存在的突变,用甘氨酸取代精氨酸(第213位),使我们能够检验这些假设。该突变并不阻止ECM结合区域的蛋白水解,但阻止了一种类羧肽酶B的酶修剪超过甘氨酸(第213位)的残基。R213G突变位于ECM结合区域,携带这种突变的个体循环系统中EC-SOD的浓度会升高。在本研究中,我们从杂合子或纯合子个体中纯化了R213G EC-SOD变体,并确定加工后亚基的C末端残基为甘氨酸(第213位)。这一发现支持了两步加工机制,并表明R213G突变不会干扰初始内切蛋白酶切割事件,但会扰乱随后C末端的修剪。